A barrier to eliminating Plasmodium vivax malaria is inadequate treatment of infected patients. 8-Aminoquinoline-based drugs clear the parasite; however, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk for hemolysis from these drugs. Understanding the performance of G6PD deficiency tests is critical for patient safety. Two quantitative assays and two qualitative test...

In a Chinese population 1,000 full-term male neonates and a further 117 jaundiced neonates of both sexes were studied in an investigation of the frequency of deficiency of erythrocyte glucose-6-phosphate dehydrogenase (G6PD). This enzyme was found to be deficient in 3.6% of male neonates. Correlation of the results with the birthplace of the 602 mothers who were known to come from Kwangtung pro...

glucose 6-phosphate dehydrogenase (g6pd) was purified from streptomyces aureofaciens and inactivated with butanedione and diethylpyrocarbonate. incubation of the enzyme with butanedione resulted in a rapid activity loss (80%) within 5 min, followed by a slow phase using a molar ratio to enzyme concentration of 100. fluorescence studies showed a conformational change in the butanedione-modified ...

Thiếu hoạt độ enzyme Glucose-6-phosphate dehydrogenase (G6PD) là một rối loạn có ý nghĩa trong xây dựng chính sách điều trị sốt rét Plasmodium vivax. Điều với thuốc primaquine (PQ) thể dẫn đến thiếu máu tan trên các bệnh nhân G6PD, do đó để dùng đủ liều PQ an toàn thúc đẩy loại trừ P. vivax, cần đánh giá biến di truyền G6PD mà hợp lý. Phương pháp: Một nghiên cứu cắt ngang 2.809 người định lượng...

Glucose 6-phosphate dehydrogenase (G6PD) was purified from Streptomyces aureofaciens and inactivated with butanedione and diethylpyrocarbonate. Incubation of the enzyme with butanedione resulted in a rapid activity loss (80%) within 5 min, followed by a slow phase using a molar ratio to enzyme concentration of 100. Fluorescence studies showed a conformational change in the butanedione-modified ...

Thiếu Glucose-6-phosphatase dehydrogenase (OMIM 305900) là bệnh lý thiếu hụt enzyme di truyền phổ biến nhất với số lượng mắc trên toàn thế giới ước tính khoảng 500 triệu người. Bệnh lặn đơn gen nhiễm sắc thể X, gây ra bởi đột G6PD (Xq28), chịu trách nhiệm mã hoá tổng hợp - enzym có vai trò xúc tác cho phản ứng đầu tiên trong chu trình pentose phosphate, NADPH – một chất đóng đặc biệt quan trọng...

the overall incidence of glucose-6-phosphate dehydrogenase (g6pd) deficiency in iranian population is estimated around 10%-14.9% . g6pd deficiency is an x-linked disorder and 80% of donors are usually male. at present, donors’ blood is not routinely screened for g6pd deficiency in iran blood bank where for detecting such enzyme deficiency, reliance is placed on pre-donation data. thus, the g6pd...

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic disorder of red blood cells in humans. It is estimated that about 400 million people are affected by this deficiency. The G6PD enzyme catalyzes the first step in the pentose phosphate pathway, leading to antioxidants that protect cells against oxidative damage. A G6PD-deficient patient, therefore, lacks the ability...

Historically, G6PD deficiency was reported for the first time in individuals who received doses of primaquine, primary drug to be addressed study, treat malaria, and triggered a symptomatic response with jaundice hematological field erythroenzymopathies. In this sense, through an integrative review, present research aimed discuss importance pharmaceutical care its relationship treatment patient...

I NVESTJGATIONS OF RED CELL GLUCOSE-6-PHOSPHATE DEHYDROGENASE ( D-glucose-6-phosphate: NADP oxidoreductase, EC 1.1.1.49; G6PD ) in different human populations have shown that more than 50 variants exist at this time.1’2 Genetic studies are compatible with X-linkage of all G6PD variants. Some variants are associated with normal enzyme activity and therefore are not accompanied by any clinical ma...